KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Inventory (2016 - 2025)

Historic Inventory for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $740.7 million.

  • Bio-Rad Laboratories' Inventory fell 253.95% to $740.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $740.7 million, marking a year-over-year decrease of 253.95%. This contributed to the annual value of $740.7 million for FY2025, which is 253.95% down from last year.
  • Bio-Rad Laboratories' Inventory amounted to $740.7 million in Q4 2025, which was down 253.95% from $783.2 million recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Inventory registered a high of $804.3 million during Q3 2024, and its lowest value of $572.2 million during Q4 2021.
  • In the last 5 years, Bio-Rad Laboratories' Inventory had a median value of $756.5 million in 2023 and averaged $719.2 million.
  • In the last 5 years, Bio-Rad Laboratories' Inventory crashed by 803.76% in 2021 and then soared by 2570.2% in 2022.
  • Bio-Rad Laboratories' Inventory (Quarter) stood at $572.2 million in 2021, then grew by 25.7% to $719.3 million in 2022, then rose by 8.51% to $780.5 million in 2023, then dropped by 2.63% to $760.0 million in 2024, then decreased by 2.54% to $740.7 million in 2025.
  • Its Inventory stands at $740.7 million for Q4 2025, versus $783.2 million for Q3 2025 and $798.8 million for Q2 2025.